PICC

Teleflex Launches New Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet in the United States

Retrieved on: 
Tuesday, May 2, 2023

The new Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet are engineered to work together to give Vascular Access Specialists more efficient and predictable PICC placement.

Key Points: 
  • The new Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet are engineered to work together to give Vascular Access Specialists more efficient and predictable PICC placement.
  • The next-generation VPS Rhythm® DLX Device provides real-time catheter tip location information by using the patient’s cardiac electrical activity.
  • The device is also available with an optional integrated ultrasound featuring a Catheter-to-Vessel ratio tool that promotes standardization in vessel measurement.
  • This device works in concert with the Arrow® PICC preloaded with the NaviCurve™ Stylet, providing innovative tip navigation/location technologies.

DISC Surgery Center at Newport Beach Further Strengthens Team

Retrieved on: 
Thursday, February 23, 2023

NEWPORT BEACH, Calif., Feb. 23, 2023 /PRNewswire/ -- DISC Surgery Center at Newport Beach ("DISC") continues to strengthen its team with two excellent new additions. Renowned spine surgeon Dr. Todd Peters has become a physician partner at DISC, while surgical services pro Andre Schotte assumes the role of ASC administrator. Both join the surgery center as it experiences a 20% annual growth over the last three years and prepares to expand its data-and-results-backed model throughout California and beyond.

Key Points: 
  • NEWPORT BEACH, Calif., Feb. 23, 2023 /PRNewswire/ -- DISC Surgery Center at Newport Beach ("DISC") continues to strengthen its team with two excellent new additions.
  • Renowned spine surgeon Dr. Todd Peters has become a physician partner at DISC, while surgical services pro Andre Schotte assumes the role of ASC administrator.
  • Both join the surgery center as it experiences a 20% annual growth over the last three years and prepares to expand its data-and-results-backed model throughout California and beyond.
  • Schotte's background also includes OR manager and various spine-lead positions with Presidio Surgery Center, SCA, Kaiser and several orthopedic and spine-focused facilities.

Historic Quartermaster Campus to Convert to the Quartermaster Science + Technology Park

Retrieved on: 
Tuesday, January 31, 2023

Philadelphia's Quartermaster Science + Technology Park will include wet and dry lab spaces for life science companies.

Key Points: 
  • Philadelphia's Quartermaster Science + Technology Park will include wet and dry lab spaces for life science companies.
  • "The Quartermaster Science + Technology Park is a transformational project for an area of Philadelphia ripe for redevelopment," said Vered Nohi, Regional Executive Director, New Business Development, SkyREM at Quartermaster.
  • The Quartermaster Science + Technology Park campus includes 24 acres with six acres of green space, creating a park-like setting.
  • The Quartermaster Science + Technology Park campus includes six buildings for a total of one million square feet of space, including wet and dry labs for research and development.

Riverside Medical Center Performs First In-Patient Use of Biomaterial-Based HydroPICC® Dual Lumen Catheter

Retrieved on: 
Monday, December 12, 2022

(AVI) today announced that Riverside Medical Center, located just outside the Chicago area, was the first in the nation to use its HydroPICC® Dual-Lumen catheter in a patient.

Key Points: 
  • (AVI) today announced that Riverside Medical Center, located just outside the Chicago area, was the first in the nation to use its HydroPICC® Dual-Lumen catheter in a patient.
  • Riverside Medical Center is a 300-bed Level II Trauma hospital that provides a full scope of inpatient and outpatient care.
  • Riverside is the area's only Magnet® Recognized hospital and ranks among the top 5 percent of hospitals nationwide for clinical performance.
  • Riverside Medical Group includes more than 140 primary and specialty care providers that deliver care at sites throughout the region.

Clinicians at 2022 AVA Scientific Meeting Discuss Observed CLABSI-Reductions With SecurePortIV® Adhesive

Retrieved on: 
Tuesday, November 8, 2022

MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- At the 2022 Association for Vascular Access ("AVA") Annual Scientific Meeting, clinicians reported statistically significant reductions in dressing changes and Central Line-Associated Bloodstream Infections ("CLABSI") as a result of utilizing Adhezion Biomedical's SecurePortIV Catheter Securement Adhesive.

Key Points: 
  • MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- At the 2022 Association for Vascular Access ("AVA") Annual Scientific Meeting, clinicians reported statistically significant reductions in dressing changes and Central Line-Associated Bloodstream Infections ("CLABSI") as a result of utilizing Adhezion Biomedical's SecurePortIV Catheter Securement Adhesive.
  • These findings were presented by clinicians representing seven separate institutions throughout the conference.
  • Study results were presented by clinicians at Baylor Scott and White Health System (TX), Carilion Children's Hospital(VA), Froedtert Hospital (WI), Ball Memorial Hospital (IN), Houston Methodist Hospital (TX) and Cabell Huntington Hospital (WV).
  • The demand for SecurePortIV adhesive continues to grow rapidly since it was recognized as a Standard of Care for vascular access securement by the Infusion Nurses Society in 2021.

Access Vascular Integrative Review Published in International Journal of Nursing and Healthcare Research Establishes Economic Impact of Biomaterial Catheters

Retrieved on: 
Monday, October 31, 2022

BILLERICA, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) , a company addressing the most common and costly vascular access complications through its advanced biomaterial platform, today shared key findings from an economic analysis published in the International Journal of Nursing and Research regarding AVIs consistently hydrophilic PICC and midline catheters.

Key Points: 
  • BILLERICA, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI) , a company addressing the most common and costly vascular access complications through its advanced biomaterial platform, today shared key findings from an economic analysis published in the International Journal of Nursing and Research regarding AVIs consistently hydrophilic PICC and midline catheters.
  • The analysis documents millions of dollars in available cost-savings for hospitals using biomaterial-based catheters to reduce vascular access complications.
  • This is a landmark finding for hospitals because it assigns a specific and significant cost-savings to a reduction in vascular access complications, said James Biggins, CEO of Access Vascular.
  • This changes the math, helping value analysis committees compute the true and total cost of new biomaterial-based vascular access catheter adoption.

NYSE to Suspend Trading Immediately in Warrants of Pivotal Investment Corporation III (PICC WS) and Commence Delisting Proceedings

Retrieved on: 
Thursday, October 27, 2022

The New York Stock Exchange (NYSE, the Exchange) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of Pivotal Investment Corporation III (the Company), each whole warrant exercisable for one share of Class A Common Stock ticker symbol PICC WS from the NYSE.

Key Points: 
  • The New York Stock Exchange (NYSE, the Exchange) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants of Pivotal Investment Corporation III (the Company), each whole warrant exercisable for one share of Class A Common Stock ticker symbol PICC WS from the NYSE.
  • Trading in the Companys warrants will be suspended immediately.
  • Trading in the Companys Class A Common Stock ticker symbol PICC and Units ticker symbol PICC.U will continue on the NYSE.
  • NYSE Regulation has determined that the Companys warrants are no longer suitable for listing based on abnormally low price levels, pursuant to Section 802.01D of the Listed Company Manual.

Dynamic Access Acquires Complete Intravenous Access Services in Pittsburgh, Pennsylvania

Retrieved on: 
Wednesday, October 26, 2022

DALLAS, Oct. 26, 2022 /PRNewswire/ -- Dynamic Access, LLC (Dynamic), a market-leading provider of outsourced vascular access services, has announced the acquisition of Complete Intravenous Access Services, Inc. (CIAS) based in Pittsburgh, Pennsylvania.

Key Points: 
  • DALLAS, Oct. 26, 2022 /PRNewswire/ -- Dynamic Access, LLC (Dynamic), a market-leading provider of outsourced vascular access services, has announced the acquisition of Complete Intravenous Access Services, Inc. (CIAS) based in Pittsburgh, Pennsylvania.
  • Kabay explained, "After nearly 30 years of providing vascular access, we decided the best way to move forward was to join forces with Dynamic.
  • I am confident that Dynamic will maintain the quality of services we have been providing and over time will enhance our offerings to meet the needs of our modern healthcare community."
  • The Joint Commission first accredited Dynamic a decade ago and has awarded Dynamic its Gold Seal of Approval.

Announcing the Launch of The VeChain Lottery: win a fantastic experience @ Nitto ATP Finals with a Tennis celebrity and tens of Digital Collectibles

Retrieved on: 
Tuesday, October 25, 2022

SAN MARINO, Oct. 25, 2022 /PRNewswire/ -- VeChain, the sustainability-focused public blockchain project, recently announced a partnership with Nitto ATP Finals.

Key Points: 
  • SAN MARINO, Oct. 25, 2022 /PRNewswire/ -- VeChain, the sustainability-focused public blockchain project, recently announced a partnership with Nitto ATP Finals.
  • In collaboration with ExPlus and World of V, the trio unveiled a free-to-enter blockchain lottery, with exclusive prizes including VIP tickets to the Nitto ATP Finals with former professional tennis star, Flavia Pennetta and tens of Digital Collectibles.
  • The collection, titled 'VeBounce', consists of 5000 unique digital tennis balls with varying aesthetic components, making some more rare than others.
  • To claim one, users must complete a 15 question tennis and VeChain-related quiz, answering 80% of questions correctly.

Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio

Retrieved on: 
Tuesday, September 27, 2022

WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) releases their new Arrow Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion.

Key Points: 
  • WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) releases their new Arrow Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion.
  • Teleflex conducted extensive research with industry-leading vascular access professionals to select the enhancements in the new Arrow Midline Catheters.
  • Teleflex is the home of Arrow, Deknatel, LMA, Pilling, QuikClot, Rsch, UroLift, and Weck trusted brands united by a common sense of purpose.
  • Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, Deknatel, LMA, Pilling, QuikClot, Rusch, UroLift, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.